甲酸治疗对大脑组织对离子失活的影响
Dalia Shaaban1, Alyssa Seerley2, Lilia Crew1
1Touro University College of Osteopathic Medicine Montana, Great Falls, MT, United States.
bioRxiv : the preprint server for biology
|September 26, 2025
概括
酸有效地使子失活,但会损害中枢神经系统组织形态. 这项研究强调了在病研究中需要使用替代性去污染方法来保护组织完整性.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 生物技术是生物技术.
背景情况:
- 子疾病带来了重大风险,因为在非活性化子蛋白质方面存在挑战.
- 酸是一种常见的生物安全方法,用于子去污染,但其对组织形态的影响尚不清楚.
研究的目的:
- 研究酸处理对中枢神经系统组织的形态影响.
- 评估酸对正常和神经退行性小鼠大脑模型的影响,包括阿尔茨海默病和慢性消耗性疾病.
主要方法:
- 鼠标大脑半球 (野生型,5xFAD,CWD模型) 用酸处理或作为对照.
- 处理和对照组织被加工,切割,染色,并通过显微镜成像.
- 定量分析评估了整个解剖区域的组织宽度,面积和结构完整性.
主要成果:
- 甲酸治疗损害了老鼠大脑组织的形态,尽管有效的离子不活化.
- 形态变化在不同大脑区域有显著差异.
- 组织年龄和神经退行现象并没有加剧酸诱导的形态损伤.
结论:
- 酸虽然对离子无活化有效,但对中枢神经系统组织形态有负面影响.
- 这些发现强调了需要开发替代性无活化技术,以保持组织完整性,用于研究和诊断.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


